Delivery Order SPE2DB22D2211-SPE2DB25FSENX
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 118ml desonide 0.05% lotion. The $1,951.71 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) on January 18, 2024, with a completion date of January 19, 2024. There was no set-aside designation used for this award. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 20, 2025, for Adapalene 0.1% Cream in 45-gram quantities. The contract is valued at $1,423.93 under a firm fixed price structure with an ultimate completion date of August 21, 2025. This award represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- This delivery order against an unidentified contract vehicle was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp for the delivery of one hundred thirty-two dollars' worth of Desoximetasone 0.05% cream in 60gm tubes. Performance will occur in Conshohocken, Pennsylvania by October 13, 2023. The pricing structure is firm fixed price. No set-aside designation was applied to this order. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,534.08 by the Defense Logistics Agency on August 19, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 20, 2025. This competitively awarded delivery order, which includes no set-aside designation, is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency for the supply of Opzelura 1.5% Cream in 60-gram units. The contract, valued at $1,310.45, carries a firm fixed price and an ultimate completion date of September 5, 2025. This delivery order represents a non-set-aside competitive award and is executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately sixteen thousand dollars to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation. The delivery order is for sixty grams of the pharmaceutical product Desoximetasone 0.25% cream to be provided by the prime contractor and delivered to a location in Conshohocken, Pennsylvania by August 24, 2023. The Defense Logistics Agency will utilize this product in support of its mission...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,473.93 by the Defense Logistics Agency on August 29, 2025, for VTAMA 1% Cream in 60-gram units. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award under open competition. Performance is scheduled for completion by September 2, 2025, with the place of performance located in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 5, 2025, for the supply of Opzelura 1.5% Cream in 60-gram quantities. The contract is valued at $14,900.19 and carries a firm fixed price structure with no set-aside designation, indicating it was awarded through open competitive procurement. Performance will be completed by August 6, 2025, with work performed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.66 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed price, non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,809.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Adapalene 0.1% Cream in 45-gram quantities, with an ultimate completion date of September 11, 2025. The award, issued on September 10, 2025, carries no set-aside designation and represents a competitively awarded contract. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSENXDelivery Order
This delivery order, issued September 9, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Desonide 0.05% Cream in 60-gram units with a ceiling value of $1,235.34. The order is firm fixed price with no set-aside designation, indicating competitive award. Performance is based in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This award represents a child contract under AmerisourceBergen's larger DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement across the Defense Health Agency and broader military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has established itself as a critical federal vendor for medical procurement. The company's extensive federal contract portfolio demonstrates capability to supply a broad range of pharmaceutical products including brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. All reviewed contract awards with the company have been competitively awarded with firm fixed pricing, reflecting AmerisourceBergen's consistent ability to meet federal procurement standards. The DLA Troop Support Medical contract enables the company to serve global pharmaceutical support needs for military healthcare programs and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/9/25 |